FIELD: medicine.
SUBSTANCE: invention includes determination of content of soluble fibrin and D-dimers, formed in the process of fibrinolysis, activated in blood sample. In method, in accordance with the claimed invention, level of D-dimers, corresponding to destruction of soluble fibrin and level of D-dimers in sample with border values of the norm, are compared.
EFFECT: test in accordance with the claimed invention can be applied for determining whether resistance to blood coagulation in patient is sufficient.
4 tbl, 3 ex, 2 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR PREDICTION OF RISK OF VENOUS THROMBOEMBOLIC COMPLICATIONS IN SEVERE BURN INJURY | 2020 |
|
RU2737277C1 |
| METHOD FOR THROMBOEMBOLIC COMPLICATIONS PREDICTION | 2016 |
|
RU2621298C1 |
| METHOD FOR QUANTITATIVE DETERMINATION OF SOLUBLE FIBRIN | 2001 |
|
RU2310200C2 |
| METHOD FOR PREDICTING PULMONARY ARTERIAL EMBOLIZATION IN ONCOLOGY PATIENTS WITH LOWER EXTREMITY PHLEBOTHROMBOSIS | 2016 |
|
RU2664448C2 |
| DIAGNOSTIC TECHNIQUE FOR LATENT INTRAVASCULAR FIBRIN FORMATION | 2010 |
|
RU2431841C1 |
| METHOD OF DETECTING THROMBINEMIA IN LARGE JOINT REPLACEMENT | 2009 |
|
RU2423697C2 |
| METHOD OF PREDICTING THROMBOSIS | 2023 |
|
RU2810460C1 |
| THROMBOLYTIC AGENTS | 1995 |
|
RU2142799C1 |
| METHOD FOR DEFINING EARLY PERIOD CRITERIA FOR DETECTING HYPERCOAGULATION SINGS IN TREATING ACUTE LEUCOSIS PATIENTS | 2002 |
|
RU2227301C2 |
| METHOD FOR PREDICTION OF THROMBOEMBOLIC COMPLICATIONS IN PATIENTS SUFFERING PULMONARY DISEASES | 2014 |
|
RU2552309C1 |
